Heat Biologics, Inc. HTBX
Day range unavailable
52-week range unavailable
Discussion (514)
Sign in to join the discussion
THIS IS -HUGE- :
Heat Biologics Highlights Publication Of Preclinical COVID-19 Vaccine Results; Says Data supports a differentiated gp96-based COVID-19 vaccine that induces systemic and tissue-specific (lung) memory CD8+ T cells
Dont get caught with your underwear around your ankles on this one. ;) If you plan to BUY, you better not WAIT
IMO, the phase ONE data is enough to warrant BUYOUT talk. Big Pharmas are in competition. They dont want a competitor buying the rights to a vaccine with such POSITIVE results, RIGHT OFF THE BAT.
I dont think we will have to WAIT to see a BUYOUT on this one.
The phase 1 data ALONE could send this OVER $20
Of course there is some risk, but, not as much as you think. They have ALREADY reported some of the BEST vaccine data to date.
A $2500 investment here COULD net you $150,000
Right now... as it stands, a buyout here COULD bring $80 a share.. RIGHT NOW
That means... if you buy enough of these shares, you will NEVER have to work, AGAIN!!!
Who will corner the vaccine market first? All vaccines will not be created EQUAL. 1st in will get 30% of the $100B annual market, or $30B. Will it be HEAT?? That would put these shares up to a potential price of $142. And, since many of these trade UP to 30X sales, a possible $4200 a share, at the current float!!!
MONSTER MOVE COMING NEXT WEEK